What is an adrenal myelolipoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is an Adrenal Myelolipoma?

An adrenal myelolipoma is a rare, benign, hormonally inactive tumor composed of mature adipose (fat) tissue and hematopoietic elements (bone marrow-like tissue) that requires no treatment or follow-up in most cases. 1, 2

Tumor Characteristics

Composition and Behavior:

  • The tumor consists of mature lipomatous tissue mixed with hematopoietic elements that resemble bone marrow 2, 3
  • These are biochemically nonfunctioning tumors—they do not produce hormones 3, 4
  • Myelolipomas are definitively benign with no malignant potential 1

Clinical Presentation:

  • Most myelolipomas are asymptomatic and discovered incidentally on imaging performed for unrelated reasons 2, 3, 4
  • Symptoms occur only when tumors become large, typically presenting as abdominal pain, flank pain, or increasing abdominal girth from tumor bulk 2, 3
  • Rare complications include spontaneous retroperitoneal hemorrhage or tumor necrosis 3

Location and Distribution:

  • Usually unilateral (one-sided), but bilateral cases have been reported 4, 5
  • Can occasionally develop in extraadrenal sites including the retroperitoneum, thorax, and pelvis 3

Diagnostic Features

Radiologic Identification:

  • Myelolipomas are readily identified on CT imaging by their characteristic macroscopic fat content 1
  • The presence of fat within the lesion on imaging is diagnostic and distinguishes myelolipomas from other adrenal masses 1

Important Caveat:

  • While myelolipomas themselves are hormonally inactive, they can coexist with other hormonally active adrenal tumors or congenital adrenal hyperplasia 6, 3
  • Hormonal evaluation is only necessary if there is clinical suspicion of a concomitant functional adenoma 6

Management Approach

No Follow-Up Required:

  • Patients with myelolipomas and other small masses containing macroscopic fat detected on initial work-up do not require further follow-up imaging or functional testing, regardless of size 1, 6, 7
  • This exemption from the typical 4 cm threshold for repeat imaging applies specifically because the fat content makes them definitively diagnosable as benign 6
  • Patients can be reassured this is a benign finding requiring no treatment 6

Surgical Indications:

  • Surgery is reserved for symptomatic tumors causing pain or mass effect 1, 3, 8
  • Some sources suggest considering resection for very large tumors (>7 cm) even if asymptomatic, though this remains controversial 8
  • Laparoscopic adrenalectomy is the preferred surgical approach when intervention is needed 5

Key Clinical Pitfall:

  • Do not subject patients with characteristic myelolipomas to unnecessary repeat imaging or hormonal testing—the diagnosis is definitive based on fat content on CT 6, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Myelolipomas of both adrenal glands.

Korean journal of urology, 2011

Guideline

Management of Adrenal Myelolipoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adrenal Incidentaloma Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adrenal myelolipoma: from tumorigenesis to management.

The Pan African medical journal, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.